Himisha Beltran, Executive Director, Center for Cancer Genomics (CCG) at Dana-Farber Cancer Institute, Professor at Harvard Medical School, shared on LinkedIn:
“Very proud of Martin Bakht for receiving a prestigious National Cancer Institute (NCI) K99/R00 Award.
Martin has been leading work in our lab studying PSMA heterogeneity and cell surface regulation in prostate cancer and how this contributes to response and resistance to LuPSMA and emerging therapies.
A well deserved recognition for his outstanding work.”
You can also read:
Evis Sala: Historic Establishment of Albania’s First National Cancer Institute
